The Effect of Arterial PaCO₂ in COPD Exacerbations with and without Peripheral Edema

1. JONES W, BRUSSELLE G, DAL NEGRO RW, FERRER M, KARDOS P, LEVY ML et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respiratory Medicine 2011; 105(1):57-66.10.1016/j.rmed.2010.09.004Search in Google Scholar

2. ALFONSO A, VERHAMME K, STURKENBOOM M, BRUSSELLE G. COPD in the general population: Prevalence, incidence and survival. Respiratory Medicine, 2011; 105(12):1872-1884.10.1016/j.rmed.2011.06.012Search in Google Scholar

3. YAZDANPANAH L, SHIDFAR F, MOOSAVI A.J, HEIDARNAZHAD H, HAGHANI H. Energy and protein intake and its relationship with pulmonary function in chronic obstructive pulmonary disease (COPD) patients. Acta Medica Iranica 2010; 48(6): 374.Search in Google Scholar

4. RAND SUTHERLAND E, CHERNIACK M. Management of chronic obstructive pulmonary disease. New Eng J Med 2004; 350: 2689-97.10.1056/NEJMra030415Search in Google Scholar

5. MOBERG M, VESTBO J, MARTINEZ G, LANGE P, RINGBAEK T. Prognostic value of C-Reactive protein, leukocytes, and vitamin D in severe chronic obstructive pulmonary disease of outcome in COPD. Scientific World Journal 2014; 2014: 140736.10.1155/2014/140736Search in Google Scholar

6. GULL MR, GEJUDO P, RODRIGUEZ-TRIGO G, GALDIZ JB, CAZOLIVE V, REGUEIRO M et al. Standards of quality care in respiratory rehabilitation in patients with chronic pulmonary disease. Arch Bronchopneumol 2012; 48:369-404.10.1016/j.arbr.2012.08.003Search in Google Scholar

7. VIJAYAN VK. Chronic obstructive pulmonary disease. Indian J Med Res 2013; 137(2):251-69.Search in Google Scholar

8. HAN MK, MCLAUGHLIN VV, CRINER GJ, MARTINEZ FJ. Pulmonary diseases and the heart. Circulation 2007; 116 (25): 2992-3005.10.1161/CIRCULATIONAHA.106.685206Search in Google Scholar

9. HEMLIN M, LJUNGMAN S, CARLSON J, MALJUKANIC S, MOBINI R, BECH-HANSSEN O et al. The effects of hypoxemia and hypercapnia on renal and heart function hemodynamics and plasma hormone levels in stable COPD patients. Clin Respir J 2007; 1(2):80-90.10.1111/j.1752-699X.2007.00031.xSearch in Google Scholar

10. PIKE D, PARRAGA G. Chronic obstructive pulmonary disease. More imaging, more phenotyping, better care? Can Respir J 2013; 20(2):90.Search in Google Scholar

11. HILDE JM1, SKJØRTEN I, GRØTTA OJ, HANSTEEN V, MELSOM MN, HISDAL J et al. Right venticular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol 2013; 62(12):1103-11.10.1016/j.jacc.2013.04.091Search in Google Scholar

12. DEKHUIJZEN PN, BROEDERS ME, TUUT MK, GROL MH. Medical treatment of COPD. Ned Tijdschr Geneeskd 2008 28; 152(26):1465-8.Search in Google Scholar

13. WEITZENBLUM E, APPRILL M, OSWALD M, CHAOUAT A, IMBS JL. Pulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edema. Chest 1994; 105(5): 1377-82.10.1378/chest.105.5.1377Search in Google Scholar

14. HODGKIN JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990; 11 (3): 550-69.10.1016/S0272-5231(21)00717-6Search in Google Scholar

15. ELÇI A, BÖREKÇI S, OVAYOLU N, ELBEK O. The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary – care community hospital. Respir 2008; 13(5): 703-7.10.1111/j.1440-1843.2008.01327.xSearch in Google Scholar

16. HOWES TQ, DEANE CR, LEVIN GE, BAUDOUIN SV, MOXHAM J. The effects of oxygen and dopamine on renal and aortic blood flow in chronic obstructive pulmonary disease with hypoxemia and hypercapnia. Am J Resp Crit Care Med 1995; 151(2): 378-383.10.1164/ajrccm.151.2.7842195Search in Google Scholar

17. RICH R. Principle of immune reactions. In: Rich R, Fleisher T. Clinical immunology. Huston: Mosby; 1995: 317-330.Search in Google Scholar

18. SKWARSKI KM, MARRISON D, BARRATT A, LEE M, MACNEEW. Effect of hypoxemia on renal hormonal balance in normal subject and in patients with COPD. Respir Med 1998; 92(12):1331-6.10.1016/S0954-6111(98)90138-XSearch in Google Scholar

19. OLAFSDOTTIR IS, GISLASON T, THJODLEIFSSON B, OLAFSSON I, GÍSLASON D, JÕGI R et al. Gender differences in the association between C-reactive protein, Lung function impairment, and COPD. Int J Chron Obstract Pulmon Dis. 2007; 2(4): 635-42Search in Google Scholar

20. ANAND IS, CHANDRASHEKHAR Y, FERRARI R, SARMA R, GULERIA R, JINDAL SK et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 1992; 86 (1):12–21.10.1161/01.CIR.86.1.12Search in Google Scholar

21. SIN DD, MAN SF. Is systemic inflammation responsible for pulmonary hypertension in COPD? Chest 2006; 130 (2): 310-12.Search in Google Scholar

22. MANNIX ET, DOWDESWELL IRG, CARLONE S, PALANGE P, ARONOFF GR, FARBER MO. The effect of oxygen on sodium excretion in hypoxemic patients with chronic obstructive lung disease. Chest 1990; 97 (4): 840-4.10.1378/chest.97.4.840Search in Google Scholar

23. CAMPBELL EJM, SHORT DS. The cause of edema in “corpulmonale” Lancet 1960; I: 1184-6.10.1016/S0140-6736(60)91062-XSearch in Google Scholar

24. REINECK HJ, STEIN JH. Sodium metabolism. In: Maxwell MH, Kleeman CR, Narins RG, eds. Clinical disorders of fluid and electrolyte metabolism. New York: McGraw-Hill, 1987: 39-40.Search in Google Scholar

25. BATHOORN E, KERSTJENS H, POSTMA D, TIMENS W, MACNEE W. Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 2008; 3(2): 217-29.10.2147/COPD.S1210262996118686731Search in Google Scholar